| |
Top Swiss standards |
|
Tigint Plus®
Collagen
MicroLactin
Lactoferrin
Colostrum
Vitamin C
The effects of MicroLactin on the
symptoms of osteoarthritis in adults: An exploratory,
randomized, double-blind, placebo-controlled trial
Background: Reconstituted hyperimmune milk (MicroLactin) has
been shown to have anti-inflammatory qualities, prompting
further research into its use for the relief of osteoarthritis
symptoms. A concentrated form of this milk product, MicroLactin
contains the high-molecular-weight and low-molecular-weight
components present in the reconstituted milk product.
Objective: The purpose of this exploratory study was to assess
the effects of MicroLactin on the symptoms of osteoarthritis in
adults.Methods: Patients aged ≥19 years with physician-diagnosed
osteoarthritis with daily joint pain, stiffness, and immobility
were eligible. This was a prospective, randomized, double-blind,
placebo-controlled trial lasting 6 weeks and having 3 treatment
arms: MicroLactin 2000 mg BID, glucosamine sulfate 500 mg TID,
and placebo. Osteoarthritis symptoms were assessed using the
Western Ontario and McMaster Universities (WOMAC) Osteoarthritis
Index.
Results: Forty-two participants were
enrolled (8 men, 34 women; mean age, 59 years [range, 34–86
years]); 35 patients (5 men, 30 women) completed the study. Due
to significant baseline differences in 3 (stiffness, activities,
and total) of the 4 (pain, stiffness, activities, and total)
WOMAC Osteoarthritis Index scores in the placebo group compared
with the MicroLactin and glucosamine sulfate—treated groups (P ≤
0.05), the results of this study were restricted to the analysis
of intragroup performance from baseline to the completion of the
study. The results showed significant improvement from baseline
to week 6 for the MicroLactin treated group for all 4 scores (P
≤ 0.005). In the glucosamine sulfate—treated group, a
significant improvement was found in stiffness and total WOMAC
Osteoarthritis Index scores from baseline to week 6 (P ≤ 0.05
for both) but not in the pain or activities scores. In the
placebo group, no significant changes were found in any of the
WOMAC Osteoarthritis Index scores.
Conclusion: The results of this study indicate that MicroLactin,
when given at a dose of 2000 mg BID, was effective in relieving
the symptoms of osteoarthritis, including joint pain, joint
stiffness, and immobility, in this patient
population.
مايكرولاكتن SWISS بروتين طبيعي
SWISS المواد الفعالة في مايكرولاكتن هي (بروتين الحليب المركز)
وهو موجود بشكل طبيعي في حليب الابقار
(Hyperimmune milk). هذا البروتين يتكون من مواد بروتينة مضادة
معينة وكذلك مواد بروتينية حيوية طبيعية دقيقة اخرى ولكنها بتركيز
ضئيل جدا حيث لا يمكن استعماله طبيا وعمليا . وباستخدام طريقة
العزل ذات براءة الاختراع الامريكية رقم 5650175 تمكن العلماء
والباحثون في شركة ستول ملك بيولوجك انك
( Stolle Milk Biologic Inc )..من عزل وتنقية وتركيز هذه المواد
البروتينية الحيوية الطبيعية الدقيقة المفيدة التي تسمى (ميكرولاكتين
) بشكل كافي يمكنهم من استعماله طبيا وعمليا باشكال غذائية
وصيدلانية.
كل الدراسات اثبتت ان مايكرولاكتن SWISS ليس له اي تأثيرات جانبية
على مرضى السكري، الضغط، الكبد، الكلى، القلب، المعده او اي حاله
مرضيه اخرى ولا يتعارض مع اي علاج اخر
_ يخفف اّلام وتصلب المفاصل المصاحبة للحركة اليومية.
_ يخفف الاّلام الناتجة من التهاب المفاصل.
_ يعمل على سرعة استعادة مرونة المفاصل والحركة الطبيعية.
.يعطي تحسن في صحة المفاصل ل (9) من كل (10) اشخاص _
Hygint cooperation with;
Stolle Milk Biologic Inc (Research & Patency)
Swiss Natural (Marketing Authorization)
Bega Bionutrient (Australian Mass Production)
|
|
|
Commitment
Believe
Shared values
Communication
Satisfaction |
|
|
